MedinCell S.A.

EPA:MEDCL.PA

17.6 (EUR) • At close November 7, 2024
Bedrijfsnaam MedinCell S.A.
Symbool MEDCL.PA
Munteenheid EUR
Prijs 17.6
Beurswaarde 511,960,170
Dividendpercentage 0%
52-weken bereik 5.85 - 19
Industrie Biotechnology
Sector Healthcare
CEO Mr. Christophe Douat
Website https://www.medincell.com

An error occurred while fetching data.

Over MedinCell S.A.

MedinCell S.A. develops various therapeutic solutions. It develops solutions based on BEPO, a technology for long-acting injectable products based on proprietary copolymers and a biocompatible solvent, which solubilizes or suspends the active pharmaceutical ingredients. The company's products in development include mdc-IRM, a subcutaneous injection in Phase III trials for use

Vergelijkbare Aandelen

UG Healthcare Corporation Limited logo

UG Healthcare Corporation Limited

8K7.SI

0.123 SGD

DBV Technologies S.A. logo

DBV Technologies S.A.

DBV.PA

2.136 EUR

Cellectis S.A. logo

Cellectis S.A.

ALCLS.PA

1.688 EUR

Amplitude Surgical SA logo

Amplitude Surgical SA

AMPLI.PA

3.16 EUR

Genfit S.A. logo

Genfit S.A.

GNFT.PA

5.39 EUR

OSE Immunotherapeutics SA logo

OSE Immunotherapeutics SA

OSE.PA

10.06 EUR

Novacyt S.A. logo

Novacyt S.A.

ALNOV.PA

0.636 EUR

Nanobiotix S.A. logo

Nanobiotix S.A.

NANO.PA

3.93 EUR

Financiële Gegevens

Cijfers zijn in miljoenen (EUR)

Cijfers zijn in miljoenen (EUR)